Dive Into Other Topics

May 08, 2023

The discovery of cell and gene therapies has opened up new possibilities for the treatment of rare diseases, especially in Japanese population

May 05, 2023

Despite many clinically failed attempts, GSK finally set to launch RSVPreF3, the first preventive respiratory syncytial virus vaccine.

May 03, 2023

Cancer is a global burden, leading to a significant number of death and disabilities worldwide. In 2020, nearly one in six deaths were related to cancer. Breast cancer, lung cancer, colon and rectum cancer, and prostate cancer are some of the major cancer types, registering the highest number of cases globally. To ...

May 01, 2023

The future of diabetes treatment is changing, as several companies are working on new treatment options for type 1 and type 2 diabetes.

Apr 28, 2023

Recent approvals of ADCs for DLBCL treatment, such as Roche's POLIVY & ADC Therapeutics' ZYNLONTA, given patients & physicians renewed hope.

Apr 26, 2023

Physiotherapy, also called physical therapy, is critical in providing holistic treatment for various disorders, injuries, and diseases. It improves mobility, strength, balance, and coordination. Especially in the case of injury, or chronic pain, it can have a long-lasting impact and greatly help manage the symptoms...

Apr 24, 2023

Bronchiectasis is a chronic respiratory condition where the bronchial tubes in the lungs become damaged, inflamed, and widened, leading to a buildup of mucus that makes breathing difficult. The condition can develop for various reasons, including infections, genetic disorders, autoimmune conditions, and other facto...

Apr 21, 2023

To address challenges, pharma giants GSK & Pfizer are bringing first vaccine for respiratory syncytial virus treatment to adult population.

Apr 19, 2023

The Body Contouring Devices market is evolving at an immense pace due to the ongoing trends and developments in the domain. Companies are developing new products

Apr 14, 2023

Vertex & CRISPR Therapeutics become first companies to submit marketing application for CRISPR gene-editing therapy exa-cel for SCD & TDT.